Search For "biological e"
CDL Kasauli clears almost 6.5 crore doses of Corbevax: Sources
Updated : 4 years, 3 months ago IST
New Delhi [India], February 22 (ANI): The Central Drugs Laboratory (CDL), Kasauli, has cleared almost 6.5 crore doses of Biological E's COVID-19 vaccine Corbevax based on safety, quality and efficacy parameters, sources said on Tuesday.
Read More
DCGI gives emergency use authorisation to COVID-19 vaccine Corbevax for 12
Updated : 4 years, 3 months ago IST
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received emergency use authorisation from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax for the 12 to 18 age group.
Read More
SEC recommends COVID-19 vaccine Corbevax for 12-18 year age group: Sources
Updated : 4 years, 3 months ago IST
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to
Read More
Quad pleased with rapid progress of COVID-19 vaccine production at facilit
Updated : 4 years, 3 months ago IST
Melbourne [Australia], February 11 (ANI): The Quad has said that it is pleased with the vaccine partnership's rapid progress in expanding vaccine production at the Biological E Ltd facility in India which aims to deliver at least 1 billion COVID-19 vaccines by the end of 2022.
Read More
Centre has placed purchase order for 5 crore Corbevax COVID-19 vaccine dos
Updated : 4 years, 3 months ago IST
New Delhi [India], February 5 (ANI): The Central government has placed an order with Hyderabad based Pharmaceutical company Biological E for five crore doses of 'Corbevax' COVID-19 vaccine with each dose costing Rs 145, said sources.
Read More
Discussions underway for WHO approval for Corbevax COVID-19 vaccine, says
Updated : 4 years, 4 months ago IST
Houston [US], December 31 (ANI): Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by the Indian government and will be manufactured by the Hyderabad-based company Biological E, one of the world's largest v
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 4 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 4 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
COVID-19 vaccine Corbevax to be rolled out by Nov end, says Managing Direc
Updated : 4 years, 7 months ago IST
Hyderabad (Telangana) [India], October 26 (ANI): To provide further momentum to the ongoing nationwide vaccination drive, the COVID-19 vaccine Corbevax vaccine will be rolled out by end of November, Biological E Limited said on Monday.
Read More
US financing body, Biological E finalise agreement to expand COVID manufac
Updated : 4 years, 7 months ago IST
Hyderabad (Telangana) [India], October 25 (ANI): In a move towards fulfilling the commitment set by the "Quad" leaders, the U.S. International Development Finance Corporation and Biological E. Limited unveiled the expansion of Biological E.'s vaccine manufacturing facility in Hyderabad on Mo
Read More
India to procure over 30 crore COVID-19 vaccine doses per month by January
Updated : 4 years, 7 months ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Read More
US Development Finance Corporation chief Marchick to visit India
Updated : 4 years, 7 months ago IST
Washington [US], October 16 (ANI): US International Development Finance Corporation (DFC) Chief Operating Officer (COO) David Marchick will be visiting India from October 24-26 with an aim to advance DFC investments helping boost global health and expand COVID-19 vaccine production capaci
Read More